Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

April 15, 2025—enVVeno Medical Corporation recently announced the presentation of findings from a subanalysis of the 1-year data from the prospe ...

Primary and secondary aortic infections are a major challenge to both the patient and the interventionalist. Endovascular treatment for aortic infections has long been met with skepticism; however, ...

Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, annou ...

Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

Microbot Medical Inc., a precommercial-stage medical technology company that is developing the Liberty endovascular robotic system ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...